256 related articles for article (PubMed ID: 30779808)
1. S100A4 inhibits cell proliferation by interfering with the S100A1-RAGE V domain.
Khan MI; Yuan T; Chou RH; Yu C
PLoS One; 2019; 14(2):e0212299. PubMed ID: 30779808
[TBL] [Abstract][Full Text] [Related]
2. S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain.
Khan MI; Su YK; Zou J; Yang LW; Chou RH; Yu C
PLoS One; 2018; 13(2):e0190545. PubMed ID: 29444082
[TBL] [Abstract][Full Text] [Related]
3. Interferon Beta Activity Is Modulated via Binding of Specific S100 Proteins.
Kazakov AS; Sofin AD; Avkhacheva NV; Denesyuk AI; Deryusheva EI; Rastrygina VA; Sokolov AS; Permyakova ME; Litus EA; Uversky VN; Permyakov EA; Permyakov SE
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322098
[TBL] [Abstract][Full Text] [Related]
4. Oxidized S100A4 inhibits the activation of protein phosphatase 5 through S100A1 in MKN‑45 gastric carcinoma cells.
Tsuchiya M; Yamaguchi F; Shimamoto S; Fujimoto T; Tokumitsu H; Tokuda M; Kobayashi R
Int J Mol Med; 2014 Dec; 34(6):1713-9. PubMed ID: 25269953
[TBL] [Abstract][Full Text] [Related]
5. Heterocomplex formation between metastasis-related protein S100A4 (Mts1) and S100A1 as revealed by the yeast two-hybrid system.
Tarabykina S; Kriajevska M; Scott DJ; Hill TJ; Lafitte D; Derrick PJ; Dodson GG; Lukanidin E; Bronstein I
FEBS Lett; 2000 Jun; 475(3):187-91. PubMed ID: 10869553
[TBL] [Abstract][Full Text] [Related]
6. Structure of Ca2+-bound S100A4 and its interaction with peptides derived from nonmuscle myosin-IIA.
Malashkevich VN; Varney KM; Garrett SC; Wilder PT; Knight D; Charpentier TH; Ramagopal UA; Almo SC; Weber DJ; Bresnick AR
Biochemistry; 2008 May; 47(18):5111-26. PubMed ID: 18410126
[TBL] [Abstract][Full Text] [Related]
7. Pentamidine blocks the interaction between mutant S100A5 and RAGE V domain and inhibits the RAGE signaling pathway.
Cho CC; Chou RH; Yu C
Biochem Biophys Res Commun; 2016 Aug; 477(2):188-94. PubMed ID: 27297108
[TBL] [Abstract][Full Text] [Related]
8. Mutually antagonistic actions of S100A4 and S100A1 on normal and metastatic phenotypes.
Wang G; Zhang S; Fernig DG; Martin-Fernandez M; Rudland PS; Barraclough R
Oncogene; 2005 Feb; 24(8):1445-54. PubMed ID: 15608682
[TBL] [Abstract][Full Text] [Related]
9. Pentamidine inhibit S100A4 - p53 interaction and decreases cell proliferation activity.
Katte RH; Chou RH; Yu C
Arch Biochem Biophys; 2020 Sep; 691():108442. PubMed ID: 32649952
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis for the interaction between stress-inducible phosphoprotein 1 (STIP1) and S100A1.
Maciejewski A; Prado VF; Prado MAM; Choy WY
Biochem J; 2017 May; 474(11):1853-1866. PubMed ID: 28408431
[TBL] [Abstract][Full Text] [Related]
11. Tranilast Blocks the Interaction between the Protein S100A11 and Receptor for Advanced Glycation End Products (RAGE) V Domain and Inhibits Cell Proliferation.
Huang YK; Chou RH; Yu C
J Biol Chem; 2016 Jul; 291(27):14300-14310. PubMed ID: 27226584
[TBL] [Abstract][Full Text] [Related]
12. Interaction in vivo and in vitro of the metastasis-inducing S100 protein, S100A4 (p9Ka) with S100A1.
Wang G; Rudland PS; White MR; Barraclough R
J Biol Chem; 2000 Apr; 275(15):11141-6. PubMed ID: 10753920
[TBL] [Abstract][Full Text] [Related]
13. Solution structure of human Mts1 (S100A4) as determined by NMR spectroscopy.
Vallely KM; Rustandi RR; Ellis KC; Varlamova O; Bresnick AR; Weber DJ
Biochemistry; 2002 Oct; 41(42):12670-80. PubMed ID: 12379109
[TBL] [Abstract][Full Text] [Related]
14. The Anti-Cancer Activity of Pentamidine and Its Derivatives (WLC-4059) Is through Blocking the Interaction between S100A1 and RAGE V Domain.
Parveen N; Chiu WJ; Shen LC; Chou RH; Sun CM; Yu C
Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671465
[TBL] [Abstract][Full Text] [Related]
15. Blocking the interface region amongst S100A6 and RAGE V domain via S100B protein.
Sung HY; Dowarha D; Chou RH; Yu C
Biochem Biophys Res Commun; 2020 Dec; 533(3):332-337. PubMed ID: 32958253
[TBL] [Abstract][Full Text] [Related]
16. S100A1 blocks the interaction between p53 and mdm2 and decreases cell proliferation activity.
Dowarha D; Chou RH; Yu C
PLoS One; 2020; 15(6):e0234152. PubMed ID: 32497081
[TBL] [Abstract][Full Text] [Related]
17. Asymmetric mode of Ca²⁺-S100A4 interaction with nonmuscle myosin IIA generates nanomolar affinity required for filament remodeling.
Elliott PR; Irvine AF; Jung HS; Tozawa K; Pastok MW; Picone R; Badyal SK; Basran J; Rudland PS; Barraclough R; Lian LY; Bagshaw CR; Kriajevska M; Barsukov IL
Structure; 2012 Apr; 20(4):654-66. PubMed ID: 22483112
[TBL] [Abstract][Full Text] [Related]
18. Multilevel Changes in Protein Dynamics upon Complex Formation of the Calcium-Loaded S100A4 with a Nonmuscle Myosin IIA Tail Fragment.
Pálfy G; Kiss B; Nyitray L; Bodor A
Chembiochem; 2016 Oct; 17(19):1829-1838. PubMed ID: 27418229
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor ligands as new extracellular targets for the metastasis-promoting S100A4 protein.
Klingelhöfer J; Møller HD; Sumer EU; Berg CH; Poulsen M; Kiryushko D; Soroka V; Ambartsumian N; Grigorian M; Lukanidin EM
FEBS J; 2009 Oct; 276(20):5936-48. PubMed ID: 19740107
[TBL] [Abstract][Full Text] [Related]
20. Interaction of extracellular S100A4 with RAGE prompts prometastatic activation of A375 melanoma cells.
Herwig N; Belter B; Wolf S; Haase-Kohn C; Pietzsch J
J Cell Mol Med; 2016 May; 20(5):825-35. PubMed ID: 26928771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
